Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
NG	O
tube	O
placement	O
Upper	O
endoscopy	O
with	O
duodenal	O
stent	O
placement	O
History	O
of	O
Present	O
Illness:	O
___	O
is	O
a	O
___	O
year	O
old	O
man	O
with	O
metastatic	O
gallbladder	O
cancer	O
on	O
palliative	O
FOLFIRI,	O
who	O
is	O
admitted	O
from	O
the	O
ED	O
with	O
abdominal	O
pain.	O
Patient	O
developed	O
new	O
abdominal	O
pain	O
starting	O
yesterday	O
around	O
noon.	O
The	O
pain	O
comes	O
and	O
goes	O
and	O
gets	O
up	O
to	O
___	O
in	O
severity.	O
It	O
is	O
located	O
in	O
the	O
RUQ	O
and	O
does	O
not	O
radiate.	O
He	O
denies	O
any	O
nausea	O
or	O
vomiting,	O
and	O
his	O
appetite	O
has	O
been	O
pretty	O
good.	O
He	O
is	O
unsure	O
of	O
when	O
his	O
last	O
BM	O
was,	O
and	O
is	O
unsure	O
if	O
he	O
is	O
passing	O
flatus.	O
He	O
otherwise	O
feels	O
well	O
without	O
fevers	O
or	O
chills.	O
No	O
headaches.	O
No	O
dysphagia	O
or	O
odynophagia.	O
No	O
CP,	O
SOB	O
or	O
cough.	O
No	O
dysuria.	O
No	O
new	O
leg	O
pain	O
or	O
swelling.	O
He	O
does	O
not	O
typically	O
have	O
cancer	O
associated	O
pain.	O
He	O
presented	O
to	O
BID-N	O
ED.	O
There,	O
CT	O
a/p	O
showed	O
infiltrative	O
mass	O
of	O
gallbladder	O
fossa	O
extending	O
into	O
the	O
anterior	O
abdominal	O
wall,	O
gastric	O
antrum	O
with	O
subsequent	O
distension	O
of	O
proximal	O
stomach,	O
and	O
tethering	O
of	O
the	O
ascending	O
colon	O
with	O
proximal	O
dilation	O
of	O
large	O
bowel	O
and	O
small	O
bowel	O
c/w	O
partial	O
obstruction.	O
Also	O
noted	O
to	O
have	O
'kink'	O
in	O
his	O
biliary	O
stent.	O
He	O
was	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
In	O
the	O
ED,	O
initial	O
VS	O
were	O
pain	O
0,	O
T	O
97.8,	O
HR	O
76,	O
P	O
___	O
RR	O
16,	O
O2	O
99%RA.	O
Labs	O
notable	O
for	O
Na	O
140,	O
K	O
3.9,	O
HCO3	O
29,	O
Cr	O
0.9,	O
ALT	O
25,	O
AST	O
23.	O
ALP	O
77,	O
TBili	O
0.5,	O
Alb	O
3.5,	O
WBC	O
4.6,	O
HCT	O
34.4,	O
PLT	O
90.	O
Surgery	O
and	O
advanced	O
endoscopy	O
were	O
consulted	O
who	O
recommended	O
against	O
intervention	O
at	O
this	O
point.	O
VS	O
prior	O
to	O
admission	O
were	O
pain	O
0,	O
T	O
97.8,	O
HR	O
76,	O
BP	O
109/66,	O
RR	O
16,	O
O2	O
99%Ra.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
Briefly,	O
he	O
was	O
dx	O
with	O
metastatic	O
adenocarcinoma	O
of	O
the	O
GB	O
in	O
___,	O
received	O
13	O
C	O
of	O
gem/cis	O
and	O
in	O
f/u	O
was	O
___	O
until	O
___	O
when	O
a	O
soft	O
tissue	O
lesion	O
was	O
identified	O
at	O
the	O
site	O
of	O
his	O
original	O
tumor	O
and	O
was	O
determined	O
to	O
be	O
a	O
recurrence.	O
Disease	O
was	O
also	O
in	O
the	O
abdominal	O
wall.	O
CXT	O
was	O
restarted	O
with	O
FOLFOX	O
-->	O
disease	O
progression	O
--->	O
___	O
he	O
had	O
___	O
opinions	O
at	O
___	O
and	O
___	O
and	O
FOLFIRI	O
was	O
recommended	O
of	O
which	O
was	O
started	O
___.	O
*	O
___	O
after	O
starting	O
C2	O
he	O
had	O
to	O
have	O
treatment	O
interrupted	O
due	O
to	O
stricture	O
-->	O
metal	O
stent	O
placed	O
(MRCP	O
___.	O
*	O
XRT	O
consulted	O
-no	O
role	O
*	O
___	O
started	O
FOLFIRI	O
and	O
was	O
"renamed"	O
C2D1	O
*	O
PET	O
___	O
(done	O
after	O
C4)	O
*	O
PET	O
___	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
Metastatic	O
gallbladder	O
cancer	O
-	O
Obstructive	O
jaundice	O
sp	O
ERCP/biliary	O
stent	O
-	O
Adrenal	O
insufficiency	O
-	O
RLE	O
DVT	O
(___)	O
-	O
Lupus	O
anticoagulant	O
-	O
Neuropathy	O
-	O
HTN	O
-	O
HLD	O
-	O
BPH	O
-	O
Hypothyroidism	O
-	O
Hx	O
of	O
GSW	O
-	O
Cataracts	O
Social	O
History:	O
___	O
Family	O
History:	O
There	O
is	O
no	O
family	O
history	O
of	O
liver	O
or	O
gallbladder	O
disease.	O
Three	O
of	O
his	O
siblings	O
have	O
lymphoma.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
=======================	O
VS:	O
T	O
97.8	O
HR	O
84	O
BP	O
103/72	O
RR	O
20	O
SAT	O
96%	O
O2	O
on	O
RA	O
GENERAL:	O
Very	O
pleasant	O
man,	O
appears	O
younger	O
than	O
stated	O
age,	O
sitting	O
up	O
comfortably	O
in	O
bed	O
in	O
no	O
distress.	O
EYES:	O
Anicteric	O
sclerea,	O
PERLL,	O
EOMI;	O
ENT:	O
Oropharynx	O
clear	O
without	O
lesion,	O
JVD	O
not	O
elevated	O
CARDIOVASCULAR:	O
Regular	O
rate	O
and	O
rhythm,	O
no	O
murmurs,	O
rubs,	O
or	O
gallops	O
RESPIRATORY:	O
Appears	O
in	O
no	O
respiratory	O
distress,	O
clear	O
to	O
auscultation	O
bilaterally,	O
no	O
crackles,	O
wheezes,	O
or	O
rhonchi	O
GASTROINTESTINAL:	O
Normal	O
bowel	O
sounds;	O
nondistended;	O
soft,	O
mildly	O
tender	O
in	O
RUQ	O
without	O
rebound	O
or	O
guarding;	O
MUSKULOSKELATAL:	O
Warm,	O
well	O
perfused	O
extremities	O
without	O
lower	O
extremity	O
edema;	O
Normal	O
bulk	O
NEURO:	O
Alert,	O
oriented,	B-Delirium
motor	O
and	O
sensory	O
function	O
grossly	O
intact	O
SKIN:	O
No	O
significant	O
rashes	O
LYMPHATIC:	O
No	O
cervical,	O
supraclavicular,	O
submandibular	O
lymphadenopathy.	O
No	O
significant	O
ecchymoses	O
DISCHARGE	O
PHYSICAL	O
EXAM	O
======================	O
VS:24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
802)	O
Temp:	O
98.3	O
(Tm	O
98.8),	O
BP:	O
124/78	O
(67-126/40	O
sitting	O
on	O
sidfe	O
of	O
bed-78),	O
HR:	O
94	O
(86-102),	O
RR:	O
18	O
(___),	O
O2	O
sat:	O
94%	O
(92%-96),	O
O2	O
delivery:	O
Ra,	O
Wt:	O
192.1	O
lb/87.14	O
kg	O
(192.1-192.2)	O
GENERAL:	O
pleasant	O
man,	O
laying	O
in	O
bed	O
in	O
no	O
acute	O
distress,	O
tired,	O
NGT	O
in	O
place	O
draining	O
dark	O
brown-green	O
fluid	O
EYES:	O
Anicteric	O
sclerea,	O
EOMI	O
ENT:	O
NGT	O
in	O
place.	O
Oropharynx	O
clear	O
without	O
lesion	O
CARDIOVASCULAR:	O
Regular	O
rate	O
and	O
rhythm,	O
no	O
murmurs,	O
rubs,	O
or	O
gallops	O
RESPIRATORY:	O
Appears	O
in	O
no	O
respiratory	O
distress,	O
clear	O
to	O
auscultation	O
bilaterally,	O
no	O
crackles,	O
wheezes,	O
or	O
rhonchi	O
GASTROINTESTINAL:	O
Normal	O
bowel	O
sounds;	O
mildly	O
distended,	O
soft	O
with	O
no	O
tenderness	O
on	O
palpation,	O
rebound	O
or	O
guarding;	O
no	O
peritoneal	O
signs	O
MUSKULOSKELATAL:	O
Warm,	O
well	O
perfused	O
extremities.	O
trace	O
non-pitting	O
edema	O
in	O
all	O
extremities	O
NEURO:	O
Alert,	O
oriented,	B-Delirium
motor	O
function	O
grossly	O
intact	O
SKIN:	O
No	O
significant	O
rashes	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
==============	O
___	O
04:50PM	O
BLOOD	O
WBC-4.6	O
RBC-3.21*	O
Hgb-11.5*	O
Hct-34.4*	O
MCV-107*	O
MCH-35.8*	O
MCHC-33.4	O
RDW-15.3	O
RDWSD-59.8*	O
Plt	O
Ct-90*	O
___	O
04:50PM	O
BLOOD	O
Neuts-40	O
Bands-0	O
___	O
Monos-12	O
Eos-3	O
Baso-0	O
Atyps-1*	O
___	O
Myelos-0	O
AbsNeut-1.84	O
AbsLymp-2.07	O
AbsMono-0.55	O
AbsEos-0.14	O
AbsBaso-0.00*	O
___	O
06:00AM	O
BLOOD	O
___	O
PTT-26.9	O
___	O
___	O
04:50PM	O
BLOOD	O
Glucose-102*	O
UreaN-15	O
Creat-0.9	O
Na-140	O
K-3.9	O
Cl-102	O
HCO3-29	O
AnGap-9*	O
___	O
04:50PM	O
BLOOD	O
ALT-25	O
AST-23	O
AlkPhos-77	O
TotBili-0.5	O
___	O
04:50PM	O
BLOOD	O
Albumin-3.5	O
___	O
06:00AM	O
BLOOD	O
Calcium-8.0*	O
Phos-3.3	O
Mg-1.9	O
___	O
05:06PM	O
BLOOD	O
Lactate-1.2	O
DISCHARGE	O
LABS	O
=============	O
___	O
04:42AM	O
BLOOD	O
WBC-4.6	O
RBC-2.56*	O
Hgb-8.7*	O
Hct-26.9*	O
MCV-105*	O
MCH-34.0*	O
MCHC-32.3	O
RDW-14.9	O
RDWSD-57.1*	O
Plt	O
___	O
___	O
04:42AM	O
BLOOD	O
Glucose-94	O
UreaN-24*	O
Creat-0.9	O
Na-141	O
K-3.6	O
Cl-105	O
HCO3-22	O
AnGap-14	O
___	O
04:42AM	O
BLOOD	O
ALT-23	O
AST-23	O
LD(LDH)-222	O
AlkPhos-70	O
TotBili-0.3	O
___	O
04:42AM	O
BLOOD	O
Calcium-7.8*	O
Phos-2.4*	O
Mg-1.9	O
MICROBIOLOGY	O
===========	O
___	O
4:52	O
pm	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
NO	O
GROWTH.	O
IMAGING	O
==========	O
___	O
CXR	O
Enteric	O
tube	O
coiled	O
in	O
the	O
stomach.	O
Partially	O
imaged	O
borderline	O
dilated	O
small	O
bowel	O
loops	O
measuring	O
up	O
to	O
3.0	O
cm.	O
If	O
concern	O
for	O
bowel	O
obstruction,	O
dedicated	O
abdominal	O
radiographs	O
or	O
cross-sectional	O
imaging	O
may	O
be	O
considered.	O
___	O
EGD	O
Likely	O
malignant	O
antro-duodenal	O
stricture	O
s/p	O
duodenal	O
stent	O
under	O
endoscopic	O
and	O
fluoroscopic	O
guidance	O
Brief	O
Hospital	O
Course:	O
SUMMARY:	O
========	O
___	O
is	O
a	O
___	O
year	O
old	O
man	O
with	O
metastatic	O
gallbladder	O
cancer	O
on	O
palliative	O
FOLFIRI,	O
who	O
is	O
admitted	O
from	O
the	O
ED	O
with	O
abdominal	O
pain	O
with	O
CT	O
findings	O
concerning	O
for	O
partial	O
bowel	O
obstruction	O
and	O
kinked	O
biliary	O
stent	O
s/p	O
duodenal	O
stent	O
placement	O
with	O
improvement	O
in	O
symptoms.	O
ACTIVE	O
ISSUES:	O
==============	O
#	O
Metastatic	O
gallbladder	O
cancer	O
#	O
RUQ	O
pain	O
#	O
Cancer	O
associated	O
pain	O
#	O
partial	O
bowel	O
obstruction	O
#	O
partial	O
gastric	O
outlet	O
obstruction	O
CT	O
A/P	O
at	O
BID-N	O
showed	O
new	O
infiltrative	O
mass	O
of	O
gallbladder	O
fossa	O
extending	O
into	O
the	O
anterior	O
abdominal	O
wall	O
(new	O
since	O
the	O
time	O
of	O
a	O
PET	O
in	O
___,	O
gastric	O
antrum	O
with	O
subsequent	O
distension	O
of	O
proximal	O
stomach,	O
and	O
tethering	O
of	O
the	O
ascending	O
colon	O
with	O
proximal	O
dilation	O
of	O
large	O
bowel	O
and	O
small	O
bowel	O
c/w	O
partial	O
obstruction.	O
Following	O
admission	O
his	O
pain	O
was	O
controlled	O
with	O
Tylenol	O
and	O
he	O
was	O
PO	O
challenged.	O
He	O
had	O
large	O
volume	O
emesis	O
and	O
ongoing	O
abdominal	O
pain	O
and	O
nausea	O
suggestive	O
of	O
ongoing	O
obstruction.	O
NGT	O
was	O
placed	O
and	O
set	O
to	O
low	O
intermittent	O
suction,	O
and	O
was	O
noted	O
to	O
be	O
draining	O
dark	O
guaiac+	O
fluid,	O
though	O
he	O
had	O
no	O
evidence	O
of	O
ongoing	O
GIB,	B-Lower_gastrointestinal_haemorrhage
and	O
Hgb	O
was	O
stable	O
this	O
admission.	O
However	O
bleeding	O
precautions	O
were	O
followed	O
including	O
IV	O
BID	O
PPI,	O
2	O
PIVs,	O
active	O
T&S.	O
Maintence	O
crystalloids	O
were	O
given	O
at	O
100cc/hr	O
while	O
NPO	O
with	O
prn	O
boluses.	O
His	O
abdominal	O
pain	O
resolved.	O
LFTs	O
were	O
monitored	O
and	O
remained	O
within	O
normal	O
limits.	O
He	O
underwent	O
upper	O
endoscopy	O
with	O
duodenal	O
stent	O
placement	O
on	O
___.	O
His	O
NGT	O
was	O
removed.	O
His	O
diet	O
was	O
advanced	O
to	O
a	O
regular,	O
low	O
fiber	O
diet,	O
which	O
he	O
was	O
instructed	O
to	O
continue	O
following	O
discharge.	O
#	O
Constipation	B-Constipation
Per	O
family	O
report,	O
he	O
had	O
not	O
been	O
taking	O
his	O
home	O
bowel	O
regimen	O
regularly	O
prior	O
to	O
admission.	O
Aggressive	O
non-stimulatory	O
bowel	O
regimen	O
with	O
miralax	O
TID	O
and	O
docusate	O
BID	O
was	O
given	O
during	O
this	O
admission.	O
He	O
was	O
given	O
lactulose	O
x1	O
on	O
___	O
and	O
bisacodyl	O
suppositories	O
as	O
needed.	O
Opiates	O
were	O
avoided	O
given	O
constipation.	B-Constipation
Upon	O
discharge,	O
he	O
was	O
instructed	O
to	O
continue	O
taking	O
decussate	O
BID,	O
with	O
Miralax	O
PRN.	O
#	O
Adrenal	O
insufficiency	O
Continued	O
his	O
home	O
hydrocortisone	O
10mg	O
qam;	O
5mg	O
q	O
2pm;	O
fludrocortisone	O
0.1mg	O
daily.	O
He	O
was	O
given	O
stress	O
dose	O
hydrocortisone	O
while	O
NPO,	O
which	O
was	O
tapered	O
and	O
discontinued	O
prior	O
to	O
discharge.	O
Due	O
to	O
low	O
blood	O
pressures,	O
his	O
home	O
hydrocortisone	O
doses	O
were	O
doubled.	O
He	O
was	O
instructed	O
to	O
continue	O
to	O
take	O
double	O
his	O
home	O
steroid	O
regimen	O
upon	O
going	O
home.	O
#	O
Anemia	O
in	O
malignancy	O
#	O
Thrombocytopenia	O
Counts	O
were	O
noted	O
to	O
be	O
dropping	O
in	O
the	O
setting	O
of	O
chemotherapy,	O
he	O
was	O
monitored	O
for	O
signs	O
and	O
symptoms	O
of	O
bleeding	O
and	O
his	O
counts	O
were	O
followed	O
with	O
daily	O
CBC.	O
#	O
Lupus	O
anticoagulant	O
#	O
History	O
of	O
DVT	O
His	O
home	O
apixiban	O
2.5	O
mg	O
PO	O
BID	O
was	O
held	O
while	O
he	O
was	O
NPO,	O
especially	O
given	O
his	O
low	O
platelets	O
and	O
concern	O
for	O
GI	B-Upper_gastrointestinal_haemorrhage
bleeding	B-Upper_gastrointestinal_haemorrhage
giving	O
dark	B-Upper_gastrointestinal_haemorrhage
emesis	B-Upper_gastrointestinal_haemorrhage
that	O
was	O
guaiac	O
positive.	O
He	O
was	O
transitioned	O
to	O
lovenox	O
40	O
mg	O
SQH	O
daily	O
for	O
DVT	O
prophylaxis	O
while	O
NPO.	O
Prior	O
to	O
discharge,	O
his	O
apixiban	O
2.5	O
BID	O
was	O
restarted	O
without	O
evidence	O
of	O
bleeding.	O
CHRONIC	O
ISSUES:	O
===============	O
#	O
Hypothyroidism:	O
his	O
home	O
levothyroxine	O
was	O
given	O
IV	O
while	O
he	O
was	O
NPO,	O
then	O
was	O
restarted	O
as	O
PO.	O
#	O
Hypertension:	O
Home	O
lisinopril	O
was	O
initially	O
held	O
while	O
NPO	O
with	O
low	O
blood	O
pressures,	O
then	O
restarted.	O
However,	O
his	O
blood	O
pressure	O
remained	O
lower	O
than	O
his	O
baseline,	O
possibly	O
due	O
to	O
adrenal	O
insufficiency	O
and	O
stress	O
of	O
acute	O
illness,	O
so	O
his	O
lisinopril	O
was	O
held	O
at	O
time	O
of	O
discharge.	O
#	O
BPH:	O
Flomax	O
was	O
held	O
initially	O
while	O
NPO,	O
then	O
restarted.	O
TRANSITIONAL	O
ISSUES:	O
====================	O
[]	O
His	O
outpatient	O
providers	O
should	O
further	O
titrate	O
his	O
bowel	O
regimen	O
medications.	O
[]	O
His	O
home	O
lisinopril	O
was	O
held	O
on	O
discharge	O
due	O
to	O
hypotension.	O
His	O
outpatient	O
providers	O
should	O
restart	O
this	O
medication	O
if	O
appropriate.	O
[]	O
He	O
was	O
instructed	O
to	O
double	O
his	O
dose	O
of	O
hydrocortisone	O
until	O
follow	O
up	O
with	O
his	O
PCP.	O
If	O
blood	O
pressures	O
stable,	O
consider	O
returning	O
to	O
his	O
normal	O
dose.	O
[]	O
The	O
outpatient	O
oncology	O
team	O
was	O
in	O
contact	O
with	O
his	O
primary	O
oncologist	O
regarding	O
his	O
treatment	O
regimen	O
given	O
the	O
progression	O
of	O
disease	O
noted	O
on	O
CT	O
scan.	O
He	O
will	O
follow	O
up	O
with	O
his	O
oncologist	O
on	O
___	O
as	O
previously	O
scheduled.	O
CODE:	O
Full	O
(confirmed)	O
EMERGENCY	O
CONTACT	O
HCP:	O
Name	O
of	O
health	O
care	O
proxy:	O
___,	O
Relationship:	O
Wife	B-Lives_alone
Phone	O
number:	O
___	O
Cell	O
phone:	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Atorvastatin	O
10	O
mg	O
PO	O
QPM	O
2.	O
diclofenac	O
sodium	O
0.1	O
%	O
BOTH	O
EYES	O
TID	O
3.	O
Fludrocortisone	O
Acetate	O
0.1	O
mg	O
PO	O
DAILY	O
4.	O
Gabapentin	O
600	O
mg	O
PO	O
BID	O
5.	O
Hydrocortisone	O
10	O
mg	O
PO	O
DAILY	O
6.	O
Levothyroxine	O
Sodium	O
88	O
mcg	O
PO	O
6X/WEEK	O
(___)	O
7.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
8.	O
Omeprazole	O
40	O
mg	O
PO	O
BID	O
9.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
DAILY	O
10.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
11.	O
Durezol	O
(difluprednate)	O
0.05	O
%	O
ophthalmic	O
(eye)	O
QID	O
12.	O
Ciprofloxacin	O
HCl	O
500	O
mg	O
PO	O
Q12H	O
13.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H	O
14.	O
Apixaban	O
2.5	O
mg	O
PO	O
BID	O
15.	O
Hydrocortisone	O
5	O
mg	O
PO	O
QPM	O
16.	O
Levothyroxine	O
Sodium	O
176	O
mcg	O
PO	O
1X/WEEK	O
(___)	O
17.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
18.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
19.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
20.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
BID	O
21.	O
Phosphorus	O
250	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
2.	O
Hydrocortisone	O
10	O
mg	O
PO	O
QPM	O
3.	O
Hydrocortisone	O
20	O
mg	O
PO	O
DAILY	O
4.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H	O
5.	O
Apixaban	O
2.5	O
mg	O
PO	O
BID	O
6.	O
Atorvastatin	O
10	O
mg	O
PO	O
QPM	O
7.	O
diclofenac	O
sodium	O
0.1	O
%	O
BOTH	O
EYES	O
TID	O
8.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
9.	O
Durezol	O
(difluprednate)	O
0.05	O
%	O
ophthalmic	O
(eye)	O
QID	O
10.	O
Fludrocortisone	O
Acetate	O
0.1	O
mg	O
PO	O
DAILY	O
11.	O
Gabapentin	O
600	O
mg	O
PO	O
BID	O
12.	O
Levothyroxine	O
Sodium	O
88	O
mcg	O
PO	O
6X/WEEK	O
(___)	O
13.	O
Levothyroxine	O
Sodium	O
176	O
mcg	O
PO	O
1X/WEEK	O
(___)	O
14.	O
Magnesium	O
Oxide	O
400	O
mg	O
PO	O
BID	O
15.	O
Omeprazole	O
40	O
mg	O
PO	O
BID	O
16.	O
Phosphorus	O
250	O
mg	O
PO	O
DAILY	O
17.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
18.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
DAILY	O
Hold	O
for	O
K	O
>	O
19.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
20.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
21.	O
HELD-	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Lisinopril	O
until	O
you	O
talk	O
to	O
your	O
primary	O
care	O
doctor	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
diagnoses:	O
Partial	O
bowel	O
obstruction	O
Partial	O
gastric	O
outlet	O
obstruction	O
Secondary	O
diagnoses:	O
Cancer	O
associated	O
pain	O
Constipation	B-Constipation
Adrenal	O
insufficiency	O
History	O
of	O
deep	O
vein	O
thrombosis	O
Lupus	O
anticoagulant	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
had	O
stomach	O
pain	O
and	O
a	O
scan	O
of	O
your	O
belly	O
made	O
us	O
worried	O
that	O
you	O
had	O
a	O
partial	O
obstruction	O
in	O
your	O
GI	O
tract.	O
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
-	O
We	O
put	O
a	O
tube	O
in	O
your	O
stomach	O
to	O
help	O
relieve	O
the	O
pressure	O
that	O
was	O
built	O
up	O
because	O
of	O
obstruction.	O
-	O
We	O
gave	O
you	O
medicines	O
to	O
control	O
your	O
nausea	O
and	O
to	O
keep	O
your	O
stool	O
soft.	O
-	O
We	O
gave	O
you	O
IV	O
fluids	O
to	O
keep	O
you	O
hydrated	O
while	O
you	O
were	O
unable	O
to	O
eat	O
and	O
drink.	O
-	O
A	O
scope	O
procedure	O
(endoscopy)	O
was	O
used	O
to	O
look	O
at	O
your	O
GI	O
tract	O
and	O
a	O
narrow	O
area	O
was	O
seen.	O
A	O
stent	O
was	O
put	O
into	O
the	O
first	O
part	O
of	O
your	O
intestines	O
(duodenum)	O
to	O
help	O
keep	O
your	O
intestine	O
open.	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Continue	O
to	O
eat	O
a	O
low	O
fiber	O
diet	O
and	O
take	O
your	O
stool	O
softeners	O
regularly.	O
You	O
should	O
try	O
to	O
have	O
a	O
bowel	O
movement	O
once	O
per	O
day.	O
If	O
you	O
are	O
straining	O
or	O
not	O
having	O
enough	O
bowel	O
movements	O
you	O
should	O
take	O
miralax	O
once	O
daily.	O
-	O
Continue	O
to	O
take	O
all	O
your	O
medicines	O
and	O
keep	O
your	O
appointments.	O
-	O
Take	O
the	O
steroids	O
at	O
double	O
dose	O
until	O
___	O
at	O
your	O
primary	O
care	O
appointment.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

